Please login to the form below

Not currently logged in
Email:
Password:

BeiGene

This page shows the latest BeiGene news and features for those working in and with pharma, biotech and healthcare.

BeiGene bags FDA approval for first product Brukinsa in lymphoma

BeiGene bags FDA approval for first product Brukinsa in lymphoma

stage. It’s just the first of several cancer drugs BeiGene is hoping to bring to the US market. ... BeiGene said it will launch Brukinsa in the coming weeks, but hasn’t yet revealed its pricing plans.

Latest news

More from news
Approximately 8 fully matching, plus 3 partially matching documents found.

Latest Intelligence

  • Chinese biotech’s global ambitions Chinese biotech’s global ambitions

    BeiGene says it as headed off any such concens by working with well-established pharma company and contract manufacturer Boehringer Ingelheim to manufacture its drug. ... Meanwhile, BeiGene is also looking to break into the still all-important US market.

  • Biopharma's Future: Made in China Biopharma's Future: Made in China

    The rise of Chinese biopharma. One home-grown pharma company which could replicate this accomplishment is Beijing-headquartered BeiGene. ... BeiGene’s CEO John Oyler told a Goldman Sachs recent conference that a Chinese biopharma sector was ready to

  • Deal Watch March 2017 Deal Watch March 2017

    In particular, the third largest deal of the month is a joint venture between the research-based biotechnology company, BeiGene, which focuses on immuno-oncology, and the Guangzhou Development District. ... The agreement, worth $330m, will build BeiGene

  • Deal Watch table for November 2013 Deal Watch table for November 2013

    BeiGene / Merck. Serono. Co-development. Expansion of collaboration to include BeiGene 290 for cancer.

More from intelligence
Approximately 2 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
M&F Health

M&F Health is a full service communications agency, dedicated to the health and wellbeing sector. We are an independent amongst...

Latest intelligence

WHITE PAPER: The increasing importance of clinical trial marketing advertising in patient recruitment
Learn why advertising is more important than ever in clinical studies...
The 'winner takes all' pricing game
Tendering has long been common in healthcare for medical devices and diagnostics; the Gulf Cooperation Council and the Jamaica Commodity Trading Company have been using pharmaceutical tendering since the 1970s....
Early diagnosis underpins NHS cancer strategy
Paul Midgley, Oli Hudson and Sarah Shield, of Wilmington Healthcare, explore how the NHS is tackling cancer in line with the Long-term Plan...

Infographics